Adverse outcome pathway (AOP) development I: strategies and principles.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M.
Villeneuve DL, et al. Among authors: lalone ca.
Toxicol Sci. 2014 Dec;142(2):312-20. doi: 10.1093/toxsci/kfu199.
Toxicol Sci. 2014.
PMID: 25466378
Free PMC article.